IL2 and neoplasm: Our group has identified a membrane form Hsp70 on tumor cells [25] as a tumor-specific recognition structure for a perforin-independent, granzyme B-mediated attack by allogeneic and autologous NK cells that have been pre-stimulated with Hsp70 peptide TKD plus low dose IL-2 [26], [27].